Green Dye 3 vs Brominated Vegetable Oil: which is worse?

What is Green Dye 3?

Green Dye 3 (Fast Green FCF) is a synthetic blue-green triarylmethane dye similar to Blue Dye 1. It produces a sea-green color and is among the least used certified US food dyes. Its chemical formula is C37H34N2Na2O10S3.

What is Brominated Vegetable Oil?

Brominated vegetable oil (BVO) is a food additive created by bonding bromine atoms to vegetable oil (typically soybean oil), creating a denser-than-water compound. When added to citrus-flavored beverages, BVO acts as an emulsifier and weighting agent, keeping citrus flavor oils evenly distributed throughout the drink rather than floating to the surface.

Documented risks

Green Dye 3: Green Dye 3 has a limited safety database compared to other certified food dyes, partly due to its infrequent use. A 1981 NTP bioassay (Technical Report 27) found statistically significant increases in urinary bladder tumors in male mice at high doses. The FDA reviewed these findings and, as with Blue 2, concluded the doses far exceeded typical human dietary exposure. Green 3 is not approved in the EU — under the EU's positive list system, only specifically approved additives may be used. Since Green 3 is not on the positive list, it is effectively banned. EFSA has not conducted a formal re-evaluation because it is not authorized for EU use. Hypersensitivity reactions have been reported. Like other synthetic triarylmethane dyes, Green 3 may cause contact dermatitis. The FDA's April 2025 phase-out announcement includes Green 3 among the eight petroleum-based synthetic dyes to be removed from the US food supply. Its already limited use means this phase-out has minimal market impact compared to Red 40 or Yellow 5.

Brominated Vegetable Oil: BVO's health concerns center on bromine accumulation in body fat and tissues. Bromine is a halogen related to iodine, and it competes with iodine in the body, potentially disrupting thyroid function—a critical concern since iodine is essential for thyroid hormone synthesis. The FDA-NIH collaborative research directly triggering the 2024 ban found adverse cardiac and thyroid effects in animal studies. This FDA-NIH work, published around 2022–2023, showed effects at dose levels closer to realistic human exposure than previous studies, removing the basis for BVO's safety determination under the Federal Food, Drug, and Cosmetic Act's 'reasonable certainty of no harm' standard. Historical case reports of human toxicity from excessive BVO consumption document bromoderma (skin lesions), memory loss, nerve damage, tremors, and fatigue in individuals consuming large volumes of BVO-containing beverages daily. Two well-documented US cases from the 1970s and 1980s involved bromism (bromine toxicity) from chronic overconsumption. Bromine bioaccumulates in fatty tissues. Long-term sub-clinical accumulation was a concern even before the FDA ban, particularly for heavy consumers of citrus sodas. The EU, Japan, and other countries banned BVO decades ago, making the US one of the last major markets to revoke approval. The FDA issued a proposed rule in November 2023 and a final rule on July 3, 2024, effective August 2, 2024, with compliance deadline August 2, 2025, after which BVO-containing products may not be manufactured for US sale.